Mirum Pharmaceuticals, Inc. Operating Lease Liability
Mirum Pharmaceuticals, Inc. (MIRM) had Operating Lease Liability of $12.87 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability $12.87M.
- 2026-03-31: Operating Lease, Liability $13.53M.
- 2025-12-31: Operating Lease, Liability $9.65M.
- 2025-09-30: Operating Lease, Liability $9.40M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $12.87M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $13.53M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $9.65M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $9.40M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $9.96M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $8.65M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $9.68M 10-K · filed 2025-02-26 | |
| 2024-09-30 | $9.99M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $9.32M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $686.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.72M 10-K · filed 2024-03-15 | |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.22M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.97M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.19M 10-K · filed 2023-03-08 | |
| 2022-09-30 | $2.09M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $300.00K 10-K · filed 2023-03-08 | $2.27M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.44M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.61M 10-K · filed 2022-03-09 | |
| 2021-09-30 | $2.78M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.94M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $3.10M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.26M 10-K · filed 2021-03-09 | |
| 2020-09-30 | $3.40M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.48M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.61M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.65M 10-K · filed 2020-03-12 | |
| 2019-09-30 | $1.46M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.46M 10-Q · filed 2019-08-28 | |
| 2019-01-31 | $1.50M 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |